Louis Denis

Louis Denis

UNVERIFIED PROFILE

Are you Louis Denis?   Register this Author

Register author
Louis Denis

Louis Denis

Publications by authors named "Louis Denis"

Are you Louis Denis?   Register this Author

50Publications

987Reads

8Profile Views

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.

J Allergy Clin Immunol 2019 Oct 26;144(4):1011-1024. Epub 2019 Jul 26.

Department of Dermatology, Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2019.07.013DOI Listing
October 2019

Being on active surveillance: the patient perspective.

Transl Androl Urol 2018 Feb;7(1):182-187

Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2017.12.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861288PMC
February 2018

Management of BPH then 2000 and now 2016 - From BPH to BPO.

Asian J Urol 2017 Jul 30;4(3):138-147. Epub 2017 Mar 30.

Oncology Center Antwerp (OCA), Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajur.2017.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717990PMC
July 2017

Prostate Cancer Units (PCU): A Patients' Perspective.

Authors:
Louis Denis

Ecancermedicalscience 2011 2;5:ed10. Epub 2011 Aug 2.

Director Oncology Centre Antwerp (OCA), Secretary Europa Uomo, Chair Wij Ook/US TOO Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2011.ed10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024834PMC
June 2014

PCA: prostate cancer, patient-centred approach or both?

BJU Int 2012 Jul 11;110(1):16-22. Epub 2012 Jan 11.

Europa Uomo, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10859.xDOI Listing
July 2012

Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine.

Invest New Drugs 2012 Feb 21;30(1):290-8. Epub 2010 Sep 21.

Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232-6307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9528-xDOI Listing
February 2012

Prostate cancer units: the patients' perspective.

Authors:
Louis Denis

Eur Urol 2011 Dec 1;60(6):1200-1. Epub 2011 Sep 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2011.08.053DOI Listing
December 2011

Prostate cancer from the horizon of the patient.

Acta Oncol 2011 Jun;50 Suppl 1:148-54

Oncology Centre Antwerp, Lange Gasthuisstraat 35-37, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2010.528446DOI Listing
June 2011

Cabazitaxel for the treatment of prostate cancer.

Expert Opin Pharmacother 2011 Apr 15;12(6):977-82. Epub 2011 Mar 15.

Department of Urology, UZ Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.567268DOI Listing
April 2011

Epilogue: different approaches for prostate cancer screening in the EU?

Eur J Cancer 2010 Nov;46(17):3120-5

Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.09.038DOI Listing
November 2010

Predictive modeling in prostate cancer. Conclusions and reflections.

Cancer 2009 Jul;115(13 Suppl):3160-2

Oncologic Centre Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24343
Publisher Site
http://dx.doi.org/10.1002/cncr.24343DOI Listing
July 2009

The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".

Cancer 2009 Jul;115(13 Suppl):3035-8

Prostate Program, Scientific Directorate, National Cancer Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24342DOI Listing
July 2009

A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS.

Neurourol Urodyn 2007 ;26(4):458-463

Oncology Centre Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nau.20136DOI Listing
August 2007

Europa uomo.

Authors:
Louis Denis

BJU Int 2007 Jun 5;99(6):1329-30. Epub 2007 Apr 5.

Oncology Centre Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.06808.xDOI Listing
June 2007

The prevention of prostate cancer.

Recent Results Cancer Res 2007 ;175:33-63

Laurel Cottage, Castleton, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-540-40901-4_4DOI Listing
May 2007

Europa Uomo: the European Prostate Cancer Coalition.

Recent Results Cancer Res 2007 ;175:267-71

Europa Uomo, Men Against Cancer, Killiney, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-540-40901-4_16DOI Listing
May 2007

First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.

Clin Cancer Res 2007 Feb;13(4):1238-45

Department of Interdisciplinary Oncology, Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1539DOI Listing
February 2007

Europa Uomo: The European Prostate Cancer Coalition.

Authors:
Louis Jean Denis

Arch Ital Urol Androl 2006 Dec;78(4):157-60

Oncology Centre Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
December 2006

Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.

Clin Cancer Res 2004 Aug;10(15):4913-21

Institute for Drug Development, Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-0469DOI Listing
August 2004

Positron emission tomography (PET): expanding the horizons of oncology drug development.

Invest New Drugs 2003 Aug;21(3):309-40

Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1025468611547DOI Listing
August 2003